A Brief Report on the Role of SPECT/TC in the Optimization of Radiotherapy Treatment with Radical Intent for Unresectable Stage III NSCLC
<b>Background:</b> The standard treatment for locally advanced non-small cell lung cancer (LA-NSCLC) is represented by concomitant chemo-radiotherapy followed by consolidation with durvalumab that ensures a 5-year survival of 46%. However, the risk of radiotherapy-induced pneumonia (RIP)...
Main Authors: | Jessica Imbrescia, Giulia Volpi, Silvia Lucchini, Cristian Toraci, Giorgio Facheris, Salvatore La Mattina, Navdeep Singh, Filippo Vaccher, Andrea Guerini, Michela Buglione di Monale e Bastia, Alessio Bruni, Paolo Borghetti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Applied Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3417/12/18/9351 |
Similar Items
-
Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience
by: Paolo Borghetti, et al.
Published: (2023-07-01) -
Myocardial perfusion imaging with <sup>99 m</sup>Tc - tetrofosmin SPECT in breast cancer patients that received postoperative radiotherapy: a case-control study
by: Sioka Chrissa, et al.
Published: (2011-11-01) -
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
by: Paolo Borghetti, et al.
Published: (2022-07-01) -
Phenylboronic acid conjugated multifunctional nanogels with 131I-labeling for targeted SPECT imaging and radiotherapy of breast adenocarcinoma
by: Lingdan Kong, et al.
Published: (2022-07-01) -
Optimal Initial Time Point of Local Radiotherapy for Unresectable Lung Adenocarcinoma: A Retrospective Analysis on Overall Arrangement of Local Radiotherapy in Advanced Lung Adenocarcinoma
by: Xinge Li, et al.
Published: (2022-02-01)